Selcia joins Eurofins Group

26-Jan-2018 - Selcia Limited announces that it has been acquired by Eurofins Scientific, a global leader in analytical testing and pharma discovery services. The acquisition of Selcia provides Eurofins with an entry into the custom radiolabelling and innovative pre-clinical, integrated drug discovery services ...

Eurofins opens new faciltiy in Livingston

28-Sep-2017 - Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has today opened a new pharmaceutical chemistry, microbiology and water microbiology facility in Livingston, Scotland, following a £4 million investment. A plaque marking the opening of the laboratories at Brucefield Industry ...

Imaging tracer allows early assessment of abdominal aortic aneurysm risk

04-Aug-2017 - Yale University researchers have developed a way in which medical imaging could potentially be used to assess a patient's rupture risk for abdominal aortic aneurysm. Delaying surgical treatment can be life-threatening, and this new type of imaging could allow physicians to diagnose disease and ...

Seeing more with PET scans

New chemistry for medical imaging

28-Jul-2017 - Researchers have found a surprisingly versatile workaround to create chemical compounds that could prove useful for medical imaging and drug development. The chemical mechanism, discovered by scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and UC ...

State-of-the-art text mining technologies for chemistry

23-Jun-2017 - The Biological Text Mining Unit at the Spanish National Cancer Research Centre (CNIO) together with with researchers at the Center for Applied Medical Research (CIMA), of the University of Navarra, in Pamplona, and the Barcelona Supercomputing Centre (BSC-CNS) have published the first exhaustive ...

One step closer to crack the mystery of bacterial adaptation to antibiotics

12-Apr-2017 - An international team including researchers from MIPT's Laboratory for Advanced Studies of Membrane Proteins have proposed an explanation of the way bacteria process external signals. By identifying the detailed structure of the protein complex used by bacteria, the scientists gained insights ...

Eurofins to invest millions in new UK facility

20-Mar-2017 - Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment. The announcement follows Eurofins’ acquisition of Exova’s pharmaceutical, ...

Evotec Signs High Throughput Screening Agreement with Active Biotech

15-Mar-2010 - Evotec AG announced that it has entered into a collaboration with Active Biotech AB to identify small molecule modulators of a priority biological target, selected by Active Biotech, involved in immune disorders and cancer. Evotec will use its expertise and technologies in assay development, ...

Link Technologies secures exclusive license for ultra sensitive diagnostic probes

Deal marks the start of ongoing collaboration between Link and The University of Manchester

01-Dec-2009 - Link Technologies Ltd has announced an exclusive license deal with The University of Manchester Intellectual Property Limited (UMIP). Under the terms of the license for the University’s “exciplex” technology, Link will manufacture and sell highly sensitive exciplex-based diagnostic reagents ...

A potential new imaging agent for early diagnosis of most serious skin cancer

05-Oct-2009 - Scientists in Australia are reporting development and testing in laboratory animals of a potential new material for diagnosing malignant melanoma, the most serious form of skin cancer. Their study is scheduled for ACS' Journal of the Medicinal Chemistry. Ivan Greguric and colleagues working ...